On the recordNovember 14, 2011
I'm concerned that duplicative regulation could slow innovation, impeding improvements to patient care as well as the job growth.
Source
congress.govKay Hagan: “I'm concerned that duplicative regulation could slow innovation, impeding improvements to patient care as well as the…”
Editor's note · Context
Hagan expresses concern about FDA's proposed regulation affecting innovation and job growth.
Share
More from Kay Hagan
Jul 10, 2014
I ask unanimous consent that the Committee on Armed Services be authorized to meet during the session of the Senate on July 10, 2013, at 9:30 a.m. The PRESIDING OFFICER. Without objection, it is so ordered. committee on finance
Jul 29, 2014
As you and I have both specified, and other folks have, too, 12 percent of workers overall have paid family leave.
Jul 14, 2014
I have heard a number of concerns from communities in North Carolina about the exclusion of the municipal securities from the high-quality liquid assets designation.
Other voices in this conversation
